Variable | hospital stays > Q3 (25 days) | ≥ 2 Hospitalizations | ICU | CPR | Dying in Hospital |
---|---|---|---|---|---|
Male vs. female | 0.70 (0.52–0.94) (0.018) | – | – | – | – |
Age | – | – | 0.98 (0.97–0.99) (0.002) | 0.98 (0.96–0.99) (< 0.001) | 0.98 (0.97–1.00) (0.014) |
DC group vs. D group | 1.52 (1.01–2.29) (0.046) | 2.26 (1.42–3.59) (0.001) | – | 0.39 (0.26–0.56) (< 0.001) | – |
Palliative care, | – | 0.99 (0.18–5.58) | (0.01–0.85) | 0.10 (0.01–0.85) | 3.29 (0.35–30.5) |
 2006–2009 |  | (0.993) | (0.035) | (0.035) | (0.295) |
 2010–2011 |  | 0.94 (0.66–1.34) (0.728) | 0.84 (0.65–1.08) (0.179) | 0.74 (0.56–0.98) (0.034) | 1.13 (0.84–1.53) (0.423) |
Admission days | – | 1.04 (1.03–1.06) (< 0.001) | 1.05 (1.04–1.06) (< 0.001) | 1.02 (1.01–1.03) (0.002) | 1.10 (1.08–1.11) (< 0.001) |
Potassium imbalancea | 0.06 (0.01–0.44) (0.006) | 2.61 (1.20–5.65) (0.015) | – | – | – |
CCI | 1.04 (1.00–1.07) (0.046) | – | – | – | – |
Nagelkerke’s R squared | 0.154 | 0.209 | 0.197 | 0.120 | 0.335 |
Hosme-Lemeshow test | 0.068 | 0.085 | < 0.001 | 0.851 | < 0.001 |